Finally, I'm able to post. COVID-19 sales IMO. US
Post# of 148165
US. order information about 3 to 5million Vail for 1 to 2 million patients. For $3 to$5B USD.
Global sales in the next 6 to 8 months.
$10 to $20B USD with 80 to 85% margin. As there is not marketing and sales team and middle man.
NET PROFIT of $8 to $16B for 2020. Or about $10 to $20 per share assets for 2020. This is more than $50 per share today for BO and even more in 2021 with $10 to $20 cash on each share.
Assumptions...
- no other competing drugs.
- Product line capacity.
- FDA approval on a timely manner.
- continuous promising results.
ALSO,; Thanks for participating in the guessing game. It was fun.